Specify a stock or a cryptocurrency in the search bar to get a summary
Eco Animal Health Group Plc
EAHECO Animal Health Group plc, together with its subsidiaries, develops, registers, and markets pharmaceutical products for animals worldwide. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites, such as worms, ticks, lices, and mange in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle. ECO Animal Health Group plc was founded in 1972 and is based in London, the United Kingdom. Address: The Grange, London, United Kingdom, N14 6BN
Analytics
WallStreet Target Price
15 759.78 GBXP/E ratio
37.25Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures EAH
Dividend Analytics EAH
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
57 %Dividend History EAH
Stock Valuation EAH
Financials EAH
Results | 2019 | Dynamics |